Vascular Patches Market, By Type (Biologic Vascular Patches, Synthetic Vascular Patches), By Application (Carotid Endarterectomy, Aortic Aneurysms, Others), By End User (Hospital and Clinics, Ambulatory Surgical Centers, Others), By Region (North America,

Vascular Patches Market, By Type (Biologic Vascular Patches, Synthetic Vascular Patches), By Application (Carotid Endarterectomy, Aortic Aneurysms, Others), By End User (Hospital and Clinics, Ambulatory Surgical Centers, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Vascular Patches Market, By Type (Biologic Vascular Patches, Synthetic Vascular Patches), By Application (Carotid Endarterectomy, Aortic Aneurysms, Others), By End User (Hospital and Clinics, Ambulatory Surgical Centers, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

After a carotid endarterectomy, vascular patches are applied. During the endarterectomy and vascular reconstruction procedures, the patches guarantee exact closures. Surface line buttressing, peripheral vascular restoration, and other repairs all require vascular patches. Additionally, femoral, renal, and iliac endarterectomy operations use the patches. Polyester urethane is the main component of vascular patches. The elastic fabric used in patches helps stop bleeding from suture holes. Vascular patches have superior handling qualities. The patches' microporous design aids in the appropriate integration of tissues. Patches made of biological or synthetic materials are highly biocompatible and have a long mechanical life.

Vascular-Patch is manufactured from polyester-urethane and is characterized by an excellent biocompatibility and proven long-term mechanical stability. The elastic material ensures minimum suture hole bleeding and a compliance which is unmatched by any other synthetic patch.

Vascular patches are used for the closure of arteriotomy with a patch reduces the effect of neointimal hyperplasia and scarring and maintains the arterial lumen diameter after the procedure. In addition, patches are usually used to close arteriotomies in other vascular beds, such as after common femoral endarterectomy or profundaplasty

Market Dynamics

The key players in the vascular patches market are focusing on the development of technologically advanced products. Collaborations, agreements to develop technologically advanced products are expected to drive market growth over the forecast period. For instance, on June 30, 2021, Axio Biosolutions, an integrated wound care company, announced U.S. FDA 510(k) clearance of its hemostatic product, Axiostat Patch, which helps control moderate to severe bleeding in vascular procedures, surgical debridement sites, punch sites, and more.

Key features of the study:

• This report provides an in-depth analysis of the global vascular patches market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global vascular patches market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include B. Braun Melsungen AG, C. R. Bard, Inc., LeMaitre Vascular, Inc., Getinge AB, L. Gore & Associates, Inc., Edwards Lifesciences Corporation, Baxter International Inc., CryoLife, Inc., Medtronic, and Admedus
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global vascular patches market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vascular patches market.

Vascular Patches Market Detailed Segmentation:

• By Type:
• Biologic Vascular Patches
• Synthetic Vascular Patches
• By Application:
• Carotid Endarterectomy
• Aortic Aneurysms
• Profundaplasty
• Others
• By End User:
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others
• By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Company Profiles
• B. Braun Melsungen AG.
• C. R. Bard, Inc.
• LeMaitre Vascular, Inc
• Getinge AB
• W. L. Gore & Associates, Inc.
• Edwards Lifesciences Corporation
• Baxter International Inc.
• CryoLife, Inc.
• Medtronic
• Admedus